Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
PLoS One ; 8(7): e68550, 2013.
Article in English | MEDLINE | ID: mdl-23922656

ABSTRACT

Rifaximin is a semi-synthetic rifamycin derivative that is used to treat different conditions including bacterial diarrhea and hepatic encephalopathy. Rifaximin is of particular interest because it is poorly adsorbed in the intestines and has minimal effect on colonic microflora. We previously demonstrated that rifaximin affected epithelial cell physiology by altering infectivity by enteric pathogens and baseline inflammation suggesting that rifaximin conferred cytoprotection against colonization and infection. Effects of rifaximin on epithelial cells were further examined by comparing the protein expression profile of cells pretreated with rifaximin, rifampin (control antibiotic), or media (untreated). Two-dimensional (2-D) gel electrophoresis identified 36 protein spots that were up- or down-regulated by over 1.7-fold in rifaximin treated cells compared to controls. 15 of these spots were down-regulated, including annexin A5, intestinal-type alkaline phosphatase, histone H4, and histone-binding protein RbbP4. 21 spots were up-regulated, including heat shock protein (HSP) 90α and fascin. Many of the identified proteins are associated with cell structure and cytoskeleton, transcription and translation, and cellular metabolism. These data suggested that in addition to its antimicrobial properties, rifaximin may alter host cell physiology that provides cytoprotective effects against bacterial pathogens.


Subject(s)
Electrophoresis, Gel, Two-Dimensional , Epithelial Cells/metabolism , Proteome/metabolism , Rifamycins/pharmacology , Cell Line , Down-Regulation/drug effects , Epithelial Cells/drug effects , Humans , Peptides/metabolism , Proteomics , Rifaximin , Up-Regulation/drug effects
3.
Vector Borne Zoonotic Dis ; 9(4): 381-7, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19650732

ABSTRACT

The efficacy of topically treating white-tailed deer with an acaricide was evaluated in a Lyme disease-endemic community of southern New York State. Twenty-four 4-Poster feeders were placed in a 5.2 km(2) treatment area in Bedford, NY, while a site in Lewisboro, NY, 4.8 km distant, served as control. Treatment periods ran from 15 September to 15 December each fall from 1997 to 2001, and from 15 March to 15 May each spring from 1998 to 2002. Corn consumption averaged 15,779 kg in fall sessions and 9054 kg in spring sessions, and a mean of 89.6% of deer in the study area showed evidence of using the feeders. Deer densities, estimated by aerial snow counts, averaged 22 and 28 deer per km(2) in Bedford and Lewisboro, respectively, over a 3-year period. Significant reductions in tick numbers on deer captured in the treatment area were noted in fall 1999 compared to deer captured at the control site. Drag sampling for nymphal host-seeking ticks indicated 63.6% control in 2001, which dropped to 54.8% the following year, but reached 80% in 2003. Higher-than-normal acorn production in 2001 that likely caused a drop in deer visitation to the feeders may have reduced efficacy against larval ticks in 2002. The 4-Poster effectively reduced the density of Ixodes scapularis, though the level of control is dependent on environmental factors that affect feeding behavior of white-tailed deer.


Subject(s)
Acaricides/administration & dosage , Deer/parasitology , Ixodes , Lyme Disease/prevention & control , Tick Control/methods , Tick Infestations/veterinary , Analysis of Variance , Animal Feed , Animals , Arachnid Vectors/growth & development , Endemic Diseases/prevention & control , Geographic Information Systems , Humans , Ixodes/growth & development , New York , Tick Control/statistics & numerical data , Tick Infestations/prevention & control , Zea mays
SELECTION OF CITATIONS
SEARCH DETAIL
...